reduced glutathione and breast cancer Targeting Metabolism: Partner in Crime in Anticancer Therapy Glutathione-Dependent Pathways in Cancer Cells

GHK-Cu's evidence is genuinely supportive but methodologically weaker

Kelly, Joseph, 1962- (Fourth ed.)

Key Takeaways BPC-157 is a Promising Peptide for Lyme Disease: Renowned for its regenerative and anti-inflammatory properties, BPC-157 offers potential benefits for those battling Lyme disease and co-infections by promoting tissue repair, reducing inflammation, and supporting immune function

bottom quartile, hazard ration (HR), 0.79

In medial collateral ligament (MCL) injury models, BPC-157 administered intraperitoneally (10 g or 10 ng/kg once daily), topically as a cream layer, or orally in drinking water consistently produced functional, biomechanical, macroscopic, and histological healing improvements throughout the 90-day study period